Form 4: Veracyte SVP Sells Shares Under 10b5-1 Plan

Veracyte's SVP, General Counsel, Annie McGuire, sold 6,466 shares of common stock for $40 per share as part of a pre-arranged 10b5-1 trading plan.

Summary

• Annie McGuire, SVP, General Counsel of Veracyte, Inc. (VCYT), disposed of 6,466 shares of common stock.
• The transaction occurred on November 5, 2025, at a price of $40 per share.
• Following this transaction, Annie McGuire beneficially owns 82,973 shares of Veracyte common stock.
• The sale was executed pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.

Sentiment

Score: 5

Explanation: The sale is a routine insider transaction under a pre-arranged 10b5-1 plan, which generally mitigates negative sentiment associated with insider selling. It's a neutral event.

Positives

• The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a reaction to new, non-public information.

Negatives

• An insider sale, even if pre-planned, reduces the insider's direct equity stake in the company.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but mitigated by the 10b5-1 plan, suggesting no immediate negative signal.

Key Dates

Recommendation

The insider sale by Veracyte's SVP, General Counsel, is a pre-scheduled transaction under a Rule 10b5-1 plan, adopted well in advance. This indicates the sale is not based on new, material non-public information and is likely for personal financial planning. Therefore, this specific filing does not provide a strong signal for a 'buy' or 'sell' recommendation, and a 'hold' stance is appropriate based solely on this information.

Keywords

Veracyte, VCYT, Insider Trading, Form 4, Annie McGuire, Stock Sale, 10b5-1 Plan, Corporate Officer